Epilepsy Ireland

Lobbying Organisation Epilepsy Ireland

Date published 04 May, 2022

Relevant Matter Public policy or programme

Public Policy Area Health

Period 1 Jan, 2022 to 30 Apr, 2022

Specific Details Discussing establishment and proposed terms of reference of proposed Sodium Valproate Inquiry

Intended results To finalise draft terms of reference and to establish inquiry at earliest opportunity

Name of person primarily responsible for lobbying on this activity Patrick McGeoghegan - Advocacy & Communications Manager; Peter Murphy; CEO

Did any Designated Public Official(DPO) or former Designated Public Official(DPO) carry out lobbying activities on your behalf in relation to this return? You must include yourself, and answer Yes, if you are a current DPO or a DPO at any time in the past. (What is a Designated Public Official?) No

Did you manage or direct a grassroots campaign? No

Was this lobbying done on behalf of a client? No

Lobbying activity

The following activities occurred for this specific Subject Matter Area.

Meeting (1)

Met with Dept Officials led by Asst Secretary Muiris O'Connor to discuss draft Terms of Reference and establishment of inquiry.

Email (6-10)

Emails regarding feedback on draft terms of reference. Emails seeking update on establishment of inquiry following meeting.

Phone call (2-5)

Phone calls regarding draft terms of reference and progress re establishment of inquiry.

Designated public officials lobbied

The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.

Muiris O’Connor Assistant Secretary (Department of Health)

Susan Mitchell Special Adviser (Department of Health)